Self-Management for Youth and Families Living With SCD - SMYLS
NCT03585543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2020-11-19
Summary
The purpose of this proposal is to integrate family-centered self-management strategies with mobile health (mHealth) technology to improve reach, self-management behaviors, and child and caregiver physical and psychosocial symptoms and quality of life. Specifically, the investigators propose to conduct feasibility testing of SMYLS, which has been adapted based on user feedback in the first phase of this study. First the investigators will work with the Medical University of South Carolina (MUSC) Pediatric Sickle Cell Clinic to identify and recruit families with children with sickle cell disease (SCD) in the community, statewide. Next, the investigators will test the feasibility of the intervention with 30 dyads of children ages 8 - 17 with sickle cell disease and their parent or primary caregiver, (N=60)
Conditions
Interventions
- BEHAVIORAL
-
Voice Crisis Alert V2
Intervention consists of a mHealth app delivered via smartphone
Sponsors & Collaborators
-
Medical University of South Carolina
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 8 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-16
- Primary Completion
- 2019-01-31
- Completion
- 2019-01-31
Countries
- United States
Study Locations
More Related Trials
-
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
NCT02766465 ·Status: COMPLETED ·Phase: PHASE2
-
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome
NCT00030550 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML
NCT00887042 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
NCT00328237 ·Status: UNKNOWN ·Phase: PHASE2
-
Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease
NCT00186810 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies
NCT02354417 ·Status: TERMINATED ·Phase: PHASE1
-
Phase I Study of Sequential Cord Blood Transplants
NCT00299767 ·Status: COMPLETED ·Phase: PHASE1
-
Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies
NCT02333838 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
NCT00841724 ·Status: COMPLETED ·Phase: PHASE2
-
Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
NCT01242267 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome
NCT00228813 ·Status: TERMINATED ·Phase: NA
-
mHealth Family Self-Management
NCT03533049 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplants Patients
NCT02119897 ·Status: COMPLETED ·Phase: NA
-
Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation
NCT04018937 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
NCT00412360 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders
NCT00005893 ·Status: COMPLETED ·Phase: NA
-
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
NCT03434730 ·Status: COMPLETED ·Phase: PHASE2
-
Siplizumab for Sickle Cell Disease Transplant
NCT06078696 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD?
NCT05905770 ·Status: RECRUITING
-
Treatment of Sickle Cell Anemia With Stem Cell Transplant
NCT01350232 ·Status: TERMINATED ·Phase: NA
-
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
NCT01682226 ·Status: COMPLETED ·Phase: PHASE2
-
Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
NCT02678143 ·Status: TERMINATED ·Phase: PHASE1
-
P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies
NCT01854567 ·Status: COMPLETED ·Phase: PHASE3
-
Stem Cell Transplant for Hemoglobinopathy
NCT00176852 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone Marrow
NCT02757885 ·Status: COMPLETED ·Phase: PHASE2